English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 91 Help

Selected(0)Clear Items/Page:    Sort:
Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variants Journal article
Li, Linjie, Shi, Kaiyuan, Gu, Yuhang, Xu, Zepeng, Shu, Chang, Li, Dedong, Sun, Junqing, Cong, Mengqing, Li, Xiaomei, Zhao, Xin, Yu, Guanghui, Hu, Songnian, Tan, Hui, Qi, Jianxun, Ma, Xiaopeng, Liu, Kefang, Gao, George F.. Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variants[J]. Structure, 2024, 32(8), 1055-1067.e6.
Authors:  Li, Linjie;  Shi, Kaiyuan;  Gu, Yuhang;  Xu, Zepeng;  Shu, Chang; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.4/4.3 | Submit date：2024/08/05
Ba.2.86  Eg.5  Eg.5.1  Hace2  Hv.1  Jn.1  Rbd  Sars-cov-2  
Effectiveness of COVID-19 Vaccination against Severe Symptoms and Death Among Geriatric Inpatients: A Retrospective Cohort Study in Macao Journal article
Xiao Zhan Zhang, Phyllis Hio Hong Wong, Kai Seng Lai, Bo Yang, Menghuan Song, Junjun Li, UNG OI LAM CAROLINA. Effectiveness of COVID-19 Vaccination against Severe Symptoms and Death Among Geriatric Inpatients: A Retrospective Cohort Study in Macao[J]. Vaccines, 2024, 12(8), 933.
Authors:  Xiao Zhan Zhang;  Phyllis Hio Hong Wong;  Kai Seng Lai;  Bo Yang;  Menghuan Song; et al.
Adobe PDF | Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.2/4.9 | Submit date：2024/08/27
Covid-19 Vaccines  Sars-cov-2 Variants  Omicron Bf.7  Vaccine Effectiveness  Mortality  Vaccination Timing  Elderly  Geriatrics  
Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies Journal article
He, Qingwen, An, Yaling, Zhou, Xuemei, Xie, Haitang, Tao, Lifeng, Li, Dedong, Zheng, Anqi, Li, Linjie, Xu, Zepeng, Yu, Shufan, Wang, Ruyue, Hu, Hua, Liu, Kefang, Wang, Qihui, Dai, Lianpan, Xu, Kun, Gao, George F.. Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies[J]. Med, 2024, 5(5), 401-413.e4.
Authors:  He, Qingwen;  An, Yaling;  Zhou, Xuemei;  Xie, Haitang;  Tao, Lifeng; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4 | Submit date：2024/05/16
Ba.2.86  Eg.5  Eg.5.1  Immune Evasion  Jn.1  Neutralizing Antibody  Rbd-dimer  Sars-cov-2  Translation To Humans  Zf2001 Vaccine  Zf2202-a  
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins Journal article
Li, Weiwei, Xu, Zepeng, Niu, Tianhui, Xie, Yufeng, Zhao, Zhennan, Li, Dedong, He, Qingwen, Sun, Wenqiao, Shi, Kaiyuan, Guo, Wenjing, Chang, Zhen, Liu, Kefang, Fan, Zheng, Qi, Jianxun, Gao, George F.. Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins[J]. EMBO Journal, 2024, 43(8), 1484-1498.
Authors:  Li, Weiwei;  Xu, Zepeng;  Niu, Tianhui;  Xie, Yufeng;  Zhao, Zhennan; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:9.4/11.0 | Submit date：2024/05/02
Immune Evasion  Omicron  Receptor Binding  Sars-cov-2  Sub-variants  
Response of unvaccinated US adults to official information about the pause in use of the johnson & johnson janssen covid-19 vaccine: Cross-sectional survey study Journal article
Mishra, Vishala, Dexter, Joseph P.. Response of unvaccinated US adults to official information about the pause in use of the johnson & johnson janssen covid-19 vaccine: Cross-sectional survey study[J]. Journal of Medical Internet Research, 2024, 26(1), e41559.
Authors:  Mishra, Vishala;  Dexter, Joseph P.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:5.8/6.7 | Submit date：2024/05/16
Cdc  Centers For Disease Control And Prevention  Covid-19  Health Communication  Health Information  Health Literacy  Public Health  Risk Perception  Sars-cov-2  Vaccine Hesitancy  Web-based Surveys  
Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao (Frontiers in Immunology, (2023), 14, (1131985), 10.3389/fimmu.2023.1131985) Other
2024-02-06
Authors:  Ng, Hoi Man;  Lei, Chon Lok;  Fu, Siyi;  Li, Enqin;  Leong, Sek In; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2024/05/16
Antibodies  Heterologous Vaccinations  Inactivated Vaccine  Macao  Mrna Vaccine  Nucleocapsid Proteins  Sars-cov-2  Spike Proteins  
Structural basis of increased binding affinities of spikes from SARS-CoV-2 Omicron variants to rabbit and hare ACE2s reveals the expanding host tendency Journal article
Shi, Kaiyuan, Li, Linjie, Luo, Chunliang, Xu, Zepeng, Huang, Baihan, Ma, Sufang, Liu, Kefang, Yu, Guanghui, Gao, George F.. Structural basis of increased binding affinities of spikes from SARS-CoV-2 Omicron variants to rabbit and hare ACE2s reveals the expanding host tendency[J]. mBio, 2024, 15(2), e02988-23.
Authors:  Shi, Kaiyuan;  Li, Linjie;  Luo, Chunliang;  Xu, Zepeng;  Huang, Baihan; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:5.1/5.9 | Submit date：2024/03/07
Ace2  Cryo-em Structure  Hare  Rabbit  Rbd  Sars-cov  Sars-cov-2  Spike (s) Proteins  
The binding and structural basis of fox ACE2 to RBDs from different sarbecoviruses Journal article
Chen, Junsen, Sun, Junqing, Xu, Zepeng, Li, Linjie, Kang, Xinrui, Luo, Chunliang, Wang, Qi, Guo, Xueyang, Li, Yan, Liu, Kefang, Wu, Ying. The binding and structural basis of fox ACE2 to RBDs from different sarbecoviruses[J]. Virologica Sinica, 2024, 39(4), 609-618.
Authors:  Chen, Junsen;  Sun, Junqing;  Xu, Zepeng;  Li, Linjie;  Kang, Xinrui; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.3/4.3 | Submit date：2024/08/05
Cryo-em Structure  Fox Ace2  Omicron  Sarbecoviruses  Sars-cov  Sars-cov-2  
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2 Journal article
Rao, Xia, Zhao, Runchu, Tong, Zhou, Guo, Shuxin, Peng, Weiyu, Liu, Kefang, Li, Shihua, Wu, Lili, Tong, Jianyu, Chai, Yan, Han, Pu, Wang, Feiran, Jia, Peng, Li, Zhaohui, Zhao, Xin, Li, Dedong, Zhang, Rong, Zhang, Xue, Zou, Weiwei, Li, Weiwei, Wang, Qihui, Gao, George Fu, Wu, Yan, Dai, Lianpan, Gao, Feng. Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2[J]. Proceedings of the National Academy of Sciences of the United States of America, 2023, 120(52), e2314193120.
Authors:  Rao, Xia;  Zhao, Runchu;  Tong, Zhou;  Guo, Shuxin;  Peng, Weiyu; et al.
Favorite | TC[WOS]:8 TC[Scopus]:9  IF:9.4/10.8 | Submit date：2024/01/02
Cryptic Epitope  Neutralizing Antibody  Omicron Ba.4/ba.5/bq.1.1/xbb Subvariant  Rbd-8  Sars-cov-2  
Classification of five SARS-CoV-2 serotypes based on RBD antigenicities Journal article
Hu, Shixiong, Wu, Chunli, Wu, Xinkai, Ma, Xuehui, Shu, Chang, Chen, Qian, Zheng, Anqi, Yang, Huiting, Lu, Jian, Du, Pei, Gao, George Fu, Wang, Qihui. Classification of five SARS-CoV-2 serotypes based on RBD antigenicities[J]. Science Bulletin, 2023, 68(23), 3003-3012.
Authors:  Hu, Shixiong;  Wu, Chunli;  Wu, Xinkai;  Ma, Xuehui;  Shu, Chang; et al.
Favorite | TC[WOS]:9 TC[Scopus]:12  IF:18.8/15.8 | Submit date：2024/02/22
Mrna Vaccine  Receptor-binding Domain (Rbd)  Sars-cov-2  Serotype Classification  Spike (s)